Evidence map›Paper›PMID 28580015›Full record

ArticleBiotechnology for biofuels2017

Removal of the product from the culture medium strongly enhances free fatty acid production by genetically engineered

Akihiro Kato, Nobuyuki Takatani, Kazutaka Ikeda, Shin-Ichi Maeda, Tatsuo Omata

Open access · goldAbstract read
In one paragraph

Article in Biotechnology for biofuels, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Triple-Gene Overexpression of the AcrA-AcrB-TolC Transporter System inInternational journal of molecular sciences · 2024
    Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Overexpression ofInternational journal of molecular sciences · 2021
    Article
  14. Article
  15. Article
  16. Review
  17. Frontiers in plant science · 2020
    Article
  18. Review
  19. Theranostics · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Akihiro KatoGraduate School of Bioagricultural Sciences, Nagoya University, Nagoya, 464-8601 Japan.
Nobuyuki TakataniGraduate School of Bioagricultural Sciences, Nagoya University, Nagoya, 464-8601 Japan.
Kazutaka IkedaLaboratory for Metabolomics, RIKEN Center for Integrative Medical Sciences, Yokohama, 230-0045 Japan.
Shin-Ichi MaedaGraduate School of Bioagricultural Sciences, Nagoya University, Nagoya, 464-8601 Japan.
Tatsuo OmataGraduate School of Bioagricultural Sciences, Nagoya University, Nagoya, 464-8601 Japan.
Nagoya University · JPJapan Science and Technology Agency · JPRIKEN Center for Integrative Medical Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCyanobacterial mutants engineered for production of free fatty acids (FFAs) secrete the products to the medium and hence are thought to be useful for biofuel production. The dAS1T mutant constructed from

resultsGrowth of dAS1T cells but not WT cells was inhibited in a liquid medium supplemented with 0.13 g L

conclusionsRemoval of FFA from the culture medium is important for improving the productivity of the FFA production system using cyanobacteria. Further increase in productivity would require an increase in both the rates of FFA production in the cell and active FFA export across the plasma membrane.

Indexed as

Biofuel productionCyanobacteriaFree fatty acidsTwo-phase culture system

Identifiers

PMID28580015
PMCPMC5452621
OpenAlexW2617149801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.